Journal article
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
Abstract
Since 1989, four Canadian Consensus Conferences on the Diagnosis and Treatment of Dementia (CCCDTDs) have provided evidence-based dementia diagnostic and treatment guidelines for Canadian clinicians and researchers. We present the results from the Neuroimaging and Fluid Biomarkers Group of the 5th CCCDTD (CCCDTD5), which addressed topics chosen by the steering committee to reflect advances in the field and build on our previous guidelines. …
Authors
Brisson M; Brodeur C; Létourneau‐Guillon L; Masellis M; Stoessl J; Tamm A; Zukotynski K; Ismail Z; Gauthier S; Rosa‐Neto P
Journal
Alzheimer's & Dementia: Translational Research & Clinical Interventions, Vol. 6, No. 1,
Publisher
Wiley
Publication Date
1 2020
DOI
10.1002/trc2.12098
ISSN
2352-8737